Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) (Q84729341)
Jump to navigation
Jump to search
scientific article published on 01 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) |
scientific article published on 01 January 2011 |
Statements
Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) (English)
Francesco Montorsi
Jacques Buvat
Hartmut Porst
Antti Kaipia
Marie Helène Colson
Beatrice Cuzin
Ignacio Moncada
Antonio Martin-Morales
Aksam Yassin
Eric Meuleman
Ian Eardley
John Daniel Dean
Ridwan Shabsigh
1 January 2011